NL-OMON22535尚未招募不适用
MODULATION OF POSTPRANDIAL LIPEMIA, INFLAMMATION, AND VASCULAR FUNCTION BY PCSK9 INHIBITION IN DIABETES
Franciscus Gasthuis0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age of 18 years of older;
排除标准
- •Current smoking
- •Impaired renal function (MDRD <60 ml/min/1.73 m2)
研究者
相似试验
已完成
4 期
MODULATION OF POSTPRANDIAL LIPEMIA, INFLAMMATION, AND VASCULAR FUNCTION BY PCSK9 INHIBITION IN DIABETES.fat loadingPostprandial lipemia100184241001331710003216NL-OMON43374Sint Franciscus Gasthuis12
进行中（未招募）
1 期
Influence of a new medicine on cholesterol and other factors after intake of a meal in patients with diabetesDiabetes mellitus type 2EUCTR2016-003253-15-NLFranciscus Gasthui
进行中（未招募）
1 期
Influence of a new diabetesmedicine on cholesterol and other factors after intake of a fatty meal in patients with diabetesDiabetes Mellitus type IIEUCTR2016-001417-24-NLFranciscus Gasthuis
尚未招募
不适用
Postprandial effects of dapagliflozin on lipemia and inflammatioType 2 Diabetes MellitusNL-OMON21590Franciscus Gasthuis, Rotterdam20
已完成
4 期
Postprandial Lipemia, Inflammation, and Vascular Function in Diabetes modulated by dapaglifloziAtherosclerosepostmeal fat influence100184241001331710003216NL-OMON46285Sint Franciscus Gasthuis14